Nursing facility
Adnan Lab INC
Adnan Lab INC was paid $8.45M by Medicaid between Mar 2023 and Jul 2023, across 4 billing codes. Its largest line is 87637, Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV — 88% of everything it billed.
33Billing provider infoADNAN LAB INC
CHICAGO, IL 60630
CHICAGO, IL 60630
33aNPI1730823147assigned 04/21/2022
33bProvider typeMental Illness Intermediate Care Facility
28Total paid$8.45M
24GClaims98,024
24DCodes billed4
24AFirst – last monthMar 2023 – Jul 2023
Compared with peers
Next to other Mental Illness Intermediate Care Facility providers in Illinois
Rank by total paid#1 of 8
Median peer was paid$91K
This provider vs. median92×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 98,024 | $8.45M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 88% | 54,991 | 42,812 | $7.48M |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 11% | 42,480 | 31,906 | $954K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 276 | 209 | $12K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 277 | 206 | $8K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialQURESHI, MOHAMMED HAMED (PRESIDENT)